Carcinogenicity tests of methyl-n-amylnitrosamine (MNAN) administered to newborn and adult rats and hamsters and adult mice and of 2-oxo-MNAN administered to adult rats

Sidney S. Mirvish, Jeannetta Nickols, Dennis D. Weisenburger, Thomas Christopher Smyrk

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

We examined the toxicity and carcinogenicity in rodents of methyl-n-amylnitrosamine (MNAN), multiple doses of which are known to induce esophageal and nasal tumors in rats. A single i.p. injection of 50-70 mg MNAN/kg into adult rats produced a 74% incidence of esophageal squamous carcinomas (mean latency, 63 weeks). Single doses of 3.0-12.5 mg/kg of MNAN injected into newborn and 3-day-old rats and hamsters were not carcinogenic in rats and only weakly carcinogenic in hamsters. The low doses (used because larger doses produced lethal interstitial pneumonia) probably explain the low carcinogenicity, despite previous findings of extensive formation of stable hydroxy-MNANs from MNAN by the esophagus of both species at these ages, which may indicate MNAN activation. One i.p. injection of 70-100 mg MNAN/kg into adult Syrian hamsters was weakly carcinogenic for the esophagus and forestomach. Six injections of 75 mg MNAN/kg into adult hamsters induced lung and nasal cavity tumors (65 and 43% incidences, respectively), but only a few esophageal tumors. Three injections of 15 mg MNAN/kg into adult Swiss mice induced lung adenomas and esophageal papillomas in 71 and 32% incidences, respectively. These results partially agreed with previous studies on hydroxy-MNAN formation by the esophagus of these species. Six s.c. injections of 75 mg 2-oxo-MNAN/kg into adult rats induced tumors of the nasal cavity, esophagus and soft tissue at the injection site in 68, 63, and 32% incidences, respectively. This does not support the view that 2-oxo-MNAN is an active metabolite of MNAN.

Original languageEnglish (US)
Pages (from-to)171-177
Number of pages7
JournalCancer Letters
Volume107
Issue number2
DOIs
StatePublished - Oct 22 1996
Externally publishedYes

Fingerprint

N-amyl-N-methylnitrosamine
Carcinogenicity Tests
Cricetinae
Esophagus
Injections
Nasal Cavity
Incidence
Neoplasms

Keywords

  • 2-oxomethylamylnitrosamine
  • Carcinogenicity
  • Hamsters
  • Methylamylnitrosamine
  • Mice
  • Rats

ASJC Scopus subject areas

  • Cancer Research
  • Molecular Biology
  • Oncology

Cite this

Carcinogenicity tests of methyl-n-amylnitrosamine (MNAN) administered to newborn and adult rats and hamsters and adult mice and of 2-oxo-MNAN administered to adult rats. / Mirvish, Sidney S.; Nickols, Jeannetta; Weisenburger, Dennis D.; Smyrk, Thomas Christopher.

In: Cancer Letters, Vol. 107, No. 2, 22.10.1996, p. 171-177.

Research output: Contribution to journalArticle

Mirvish, Sidney S. ; Nickols, Jeannetta ; Weisenburger, Dennis D. ; Smyrk, Thomas Christopher. / Carcinogenicity tests of methyl-n-amylnitrosamine (MNAN) administered to newborn and adult rats and hamsters and adult mice and of 2-oxo-MNAN administered to adult rats. In: Cancer Letters. 1996 ; Vol. 107, No. 2. pp. 171-177.
@article{1776124cd1204e7ab364e3ea66f3b98c,
title = "Carcinogenicity tests of methyl-n-amylnitrosamine (MNAN) administered to newborn and adult rats and hamsters and adult mice and of 2-oxo-MNAN administered to adult rats",
abstract = "We examined the toxicity and carcinogenicity in rodents of methyl-n-amylnitrosamine (MNAN), multiple doses of which are known to induce esophageal and nasal tumors in rats. A single i.p. injection of 50-70 mg MNAN/kg into adult rats produced a 74{\%} incidence of esophageal squamous carcinomas (mean latency, 63 weeks). Single doses of 3.0-12.5 mg/kg of MNAN injected into newborn and 3-day-old rats and hamsters were not carcinogenic in rats and only weakly carcinogenic in hamsters. The low doses (used because larger doses produced lethal interstitial pneumonia) probably explain the low carcinogenicity, despite previous findings of extensive formation of stable hydroxy-MNANs from MNAN by the esophagus of both species at these ages, which may indicate MNAN activation. One i.p. injection of 70-100 mg MNAN/kg into adult Syrian hamsters was weakly carcinogenic for the esophagus and forestomach. Six injections of 75 mg MNAN/kg into adult hamsters induced lung and nasal cavity tumors (65 and 43{\%} incidences, respectively), but only a few esophageal tumors. Three injections of 15 mg MNAN/kg into adult Swiss mice induced lung adenomas and esophageal papillomas in 71 and 32{\%} incidences, respectively. These results partially agreed with previous studies on hydroxy-MNAN formation by the esophagus of these species. Six s.c. injections of 75 mg 2-oxo-MNAN/kg into adult rats induced tumors of the nasal cavity, esophagus and soft tissue at the injection site in 68, 63, and 32{\%} incidences, respectively. This does not support the view that 2-oxo-MNAN is an active metabolite of MNAN.",
keywords = "2-oxomethylamylnitrosamine, Carcinogenicity, Hamsters, Methylamylnitrosamine, Mice, Rats",
author = "Mirvish, {Sidney S.} and Jeannetta Nickols and Weisenburger, {Dennis D.} and Smyrk, {Thomas Christopher}",
year = "1996",
month = "10",
day = "22",
doi = "10.1016/0304-3835(96)04352-2",
language = "English (US)",
volume = "107",
pages = "171--177",
journal = "Cancer Letters",
issn = "0304-3835",
publisher = "Elsevier Ireland Ltd",
number = "2",

}

TY - JOUR

T1 - Carcinogenicity tests of methyl-n-amylnitrosamine (MNAN) administered to newborn and adult rats and hamsters and adult mice and of 2-oxo-MNAN administered to adult rats

AU - Mirvish, Sidney S.

AU - Nickols, Jeannetta

AU - Weisenburger, Dennis D.

AU - Smyrk, Thomas Christopher

PY - 1996/10/22

Y1 - 1996/10/22

N2 - We examined the toxicity and carcinogenicity in rodents of methyl-n-amylnitrosamine (MNAN), multiple doses of which are known to induce esophageal and nasal tumors in rats. A single i.p. injection of 50-70 mg MNAN/kg into adult rats produced a 74% incidence of esophageal squamous carcinomas (mean latency, 63 weeks). Single doses of 3.0-12.5 mg/kg of MNAN injected into newborn and 3-day-old rats and hamsters were not carcinogenic in rats and only weakly carcinogenic in hamsters. The low doses (used because larger doses produced lethal interstitial pneumonia) probably explain the low carcinogenicity, despite previous findings of extensive formation of stable hydroxy-MNANs from MNAN by the esophagus of both species at these ages, which may indicate MNAN activation. One i.p. injection of 70-100 mg MNAN/kg into adult Syrian hamsters was weakly carcinogenic for the esophagus and forestomach. Six injections of 75 mg MNAN/kg into adult hamsters induced lung and nasal cavity tumors (65 and 43% incidences, respectively), but only a few esophageal tumors. Three injections of 15 mg MNAN/kg into adult Swiss mice induced lung adenomas and esophageal papillomas in 71 and 32% incidences, respectively. These results partially agreed with previous studies on hydroxy-MNAN formation by the esophagus of these species. Six s.c. injections of 75 mg 2-oxo-MNAN/kg into adult rats induced tumors of the nasal cavity, esophagus and soft tissue at the injection site in 68, 63, and 32% incidences, respectively. This does not support the view that 2-oxo-MNAN is an active metabolite of MNAN.

AB - We examined the toxicity and carcinogenicity in rodents of methyl-n-amylnitrosamine (MNAN), multiple doses of which are known to induce esophageal and nasal tumors in rats. A single i.p. injection of 50-70 mg MNAN/kg into adult rats produced a 74% incidence of esophageal squamous carcinomas (mean latency, 63 weeks). Single doses of 3.0-12.5 mg/kg of MNAN injected into newborn and 3-day-old rats and hamsters were not carcinogenic in rats and only weakly carcinogenic in hamsters. The low doses (used because larger doses produced lethal interstitial pneumonia) probably explain the low carcinogenicity, despite previous findings of extensive formation of stable hydroxy-MNANs from MNAN by the esophagus of both species at these ages, which may indicate MNAN activation. One i.p. injection of 70-100 mg MNAN/kg into adult Syrian hamsters was weakly carcinogenic for the esophagus and forestomach. Six injections of 75 mg MNAN/kg into adult hamsters induced lung and nasal cavity tumors (65 and 43% incidences, respectively), but only a few esophageal tumors. Three injections of 15 mg MNAN/kg into adult Swiss mice induced lung adenomas and esophageal papillomas in 71 and 32% incidences, respectively. These results partially agreed with previous studies on hydroxy-MNAN formation by the esophagus of these species. Six s.c. injections of 75 mg 2-oxo-MNAN/kg into adult rats induced tumors of the nasal cavity, esophagus and soft tissue at the injection site in 68, 63, and 32% incidences, respectively. This does not support the view that 2-oxo-MNAN is an active metabolite of MNAN.

KW - 2-oxomethylamylnitrosamine

KW - Carcinogenicity

KW - Hamsters

KW - Methylamylnitrosamine

KW - Mice

KW - Rats

UR - http://www.scopus.com/inward/record.url?scp=0030598149&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0030598149&partnerID=8YFLogxK

U2 - 10.1016/0304-3835(96)04352-2

DO - 10.1016/0304-3835(96)04352-2

M3 - Article

VL - 107

SP - 171

EP - 177

JO - Cancer Letters

JF - Cancer Letters

SN - 0304-3835

IS - 2

ER -